Research programme: sodium glucose co-transporter inhibitors - TheratechnologiesAlternative Names: Sodium glucose co-transporter inhibitors research programme - Theratechnologies
Latest Information Update: 10 Jan 2007
At a glance
- Originator Theratechnologies
- Mechanism of Action Sodium-glucose transport protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 09 Sep 2004 Preclinical trials in Type-2 diabetes mellitus in Canada (unspecified route)